Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.23.17 (
PCE
)
1,301
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We report the PCDTBT {Poly[N-9'-heptadecanyl-2,7-carbazole-alt-5,5-(4',7'-di-2-thienyl-2',1',3'-benzothiadiazole)]}, an alternating copolymer of 2,7-carbazole and dithienyl-2,1,3-benzothiazole, has high molecular weight and narrow molecular weight distribution. Our PCDTBT can be successfully prepared as good yield by using tetrakis(
triphenylphosphine
)palladium [Pd(PPh3)4] catalyst instead of Pd2dba3/P(o-Tol)3 catalyst. From the UV/Vis absorption spectroscopy, we can observe that absorption bands of PCDTBT are bathochromically shifted by increasing the molecular weight, that is to say, our high molecular weight PCDTBT can absorb much longer wavelength light compare to low molecular weight PCDTBT. The best performance can be obtained from device based on the mixture of PCDTBT (polymer-30) and PC70BM {[6,6]-phenyl C71-butyric acid methyl ester} (1:4) as an active layer, which shows 4.50% of
PCE
with 10.1 mA/cm2 of short-circuit current density (J(SC)), 0.85 V of open-circuit voltage (V(OC)), and 52.3% of fill factor which is very similar with Leclerc's published result.
...
PMID:Preparation and characterization of high molecular weight low bandgap polymers based on poly(2,7-carbazole)s for organic solar cells. 2285 85